TippingPoint Biosciences
Therapeutics company focused on drug discovery targeting the aberrant DNA in cancer cells.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Seed | ||
* | N/A | Seed | |
| Total Funding | - | ||
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Seed | ||
* | N/A | Seed | |
| Total Funding | - | ||